$LECT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Axogen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Axogen, Inc.. Get notifications about new insider transactions in Axogen, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 30 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP of Clin. & Trans ... | Option Exercise | M | 2.86 | 10,000 | 28,600 | 0 | |
Apr 30 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP of Clin. & Trans ... | Buy | M | 2.86 | 10,000 | 28,600 | 78,082 | 68.1 K to 78.1 K (+14.69 %) |
Apr 20 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | M | 5.09 | 100,000 | 509,000 | 110,000 | |
Apr 20 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Buy | M | 5.09 | 100,000 | 509,000 | 765,912 | 665.9 K to 765.9 K (+15.02 %) |
Mar 29 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | M | 3.67 | 15,500 | 56,885 | 0 | |
Mar 29 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | M | 3.67 | 19,000 | 69,730 | 0 | |
Mar 29 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Buy | M | 3.67 | 34,500 | 126,615 | 665,912 | 631.4 K to 665.9 K (+5.46 %) |
Mar 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affai ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
Mar 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP Regulatory Affai ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
Mar 18 2021 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Option Exercise | A | 0.00 | 13,100 | 0 | 24,900 | |
Mar 18 2021 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
Mar 18 2021 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
Mar 18 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
Mar 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Mar 18 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | A | 20.91 | 76,600 | 1,601,706 | 76,600 | |
Mar 18 2021 | LECT | Axogen, Inc. | Ottinger Bradley | General Counsel and ... | Option Exercise | A | 0.00 | 7,690 | 0 | 19,490 | |
Mar 18 2021 | LECT | Axogen, Inc. | Ottinger Bradley | General Counsel and ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
Mar 18 2021 | LECT | Axogen, Inc. | Ottinger Bradley | General Counsel and ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
Mar 18 2021 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | MARIANI PETER J | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 30,500 | 0 | 30,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | MARIANI PETER J | EVP & Chief Financi ... | Option Exercise | A | 20.91 | 61,000 | 1,275,510 | 61,000 | |
Mar 18 2021 | LECT | Axogen, Inc. | Ottinger Bradley | General Counsel and ... | Option Exercise | A | 0.00 | 7,690 | 0 | 19,490 | |
Mar 18 2021 | LECT | Axogen, Inc. | Ottinger Bradley | General Counsel and ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
Mar 18 2021 | LECT | Axogen, Inc. | Ottinger Bradley | General Counsel and ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Option Exercise | A | 0.00 | 11,800 | 0 | 11,800 | |
Mar 18 2021 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Option Exercise | A | 20.91 | 23,500 | 491,385 | 23,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | MARIANI PETER J | EVP & Chief Financi ... | Option Exercise | A | 0.00 | 30,500 | 0 | 30,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Option Exercise | A | 0.00 | 16,500 | 0 | 16,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | MARIANI PETER J | EVP & Chief Financi ... | Option Exercise | A | 20.91 | 61,000 | 1,275,510 | 61,000 | |
Mar 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Option Exercise | A | 20.91 | 34,000 | 710,940 | 34,000 | |
Mar 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Option Exercise | A | 0.00 | 16,500 | 0 | 16,500 | |
Mar 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Option Exercise | A | 20.91 | 34,000 | 710,940 | 34,000 | |
Feb 19 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 19.15 | 1,808 | 34,623 | 40,839 | 42.6 K to 40.8 K (-4.24 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Payment of Exercise | F | 18.71 | 406 | 7,596 | 7,046 | 7.5 K to 7 K (-5.45 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Scopelianos Angelo | Chief R&D Officer | Grant | A | 0.00 | 1,325 | 0 | 7,452 | 6.1 K to 7.5 K (+21.63 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP, Regulatory & Qu ... | Payment of Exercise | F | 18.71 | 361 | 6,754 | 13,936 | 14.3 K to 13.9 K (-2.53 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP, Regulatory & Qu ... | Grant | A | 0.00 | 1,181 | 0 | 14,297 | 13.1 K to 14.3 K (+9.00 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP, Regulatory & Qu ... | Payment of Exercise | F | 18.70 | 590 | 11,033 | 13,116 | 13.7 K to 13.1 K (-4.30 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Friedman Mark Louis | VP, Regulatory & Qu ... | Grant | A | 0.00 | 1,930 | 0 | 13,706 | 11.8 K to 13.7 K (+16.39 %) |
Feb 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 18.70 | 322 | 6,021 | 68,082 | 68.4 K to 68.1 K (-0.47 %) |
Feb 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 1,181 | 0 | 68,404 | 67.2 K to 68.4 K (+1.76 %) |
Feb 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 18.70 | 1,542 | 28,835 | 67,223 | 68.8 K to 67.2 K (-2.24 %) |
Feb 18 2021 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 5,050 | 0 | 68,765 | 63.7 K to 68.8 K (+7.93 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Payment of Exercise | F | 18.70 | 903 | 16,886 | 3,223 | 4.1 K to 3.2 K (-21.89 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Sandberg Eric | Chief Commercial Of ... | Grant | A | 0.00 | 2,531 | 0 | 4,126 | 1.6 K to 4.1 K (+158.68 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Payment of Exercise | F | 18.71 | 207 | 3,873 | 42,647 | 42.9 K to 42.6 K (-0.48 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 675 | 0 | 42,854 | 42.2 K to 42.9 K (+1.60 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Payment of Exercise | F | 18.71 | 590 | 11,039 | 42,179 | 42.8 K to 42.2 K (-1.38 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 1,930 | 0 | 42,769 | 40.8 K to 42.8 K (+4.73 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Payment of Exercise | F | 18.70 | 545 | 10,192 | 252,352 | 252.9 K to 252.4 K (-0.22 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 1,784 | 0 | 252,897 | 251.1 K to 252.9 K (+0.71 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Payment of Exercise | F | 18.70 | 1,032 | 19,298 | 251,113 | 252.1 K to 251.1 K (-0.41 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 3,377 | 0 | 252,145 | 248.8 K to 252.1 K (+1.36 %) |
Feb 18 2021 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Payment of Exercise | F | 18.71 | 406 | 7,596 | 5,584 | 6 K to 5.6 K (-6.78 %) |
Feb 18 2021 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Grant | A | 0.00 | 1,325 | 0 | 5,990 | 4.7 K to 6 K (+28.40 %) |
Feb 18 2021 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Payment of Exercise | F | 18.70 | 789 | 14,754 | 18,234 | 19 K to 18.2 K (-4.15 %) |
Feb 18 2021 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 3,157 | 0 | 19,023 | 15.9 K to 19 K (+19.90 %) |
Feb 18 2021 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Payment of Exercise | F | 18.71 | 2,165 | 40,507 | 15,866 | 18 K to 15.9 K (-12.01 %) |
Feb 18 2021 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 7,655 | 0 | 18,031 | 10.4 K to 18 K (+73.78 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Payment of Exercise | F | 18.71 | 3,504 | 65,560 | 631,412 | 634.9 K to 631.4 K (-0.55 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 13,978 | 0 | 634,916 | 620.9 K to 634.9 K (+2.25 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Payment of Exercise | F | 18.71 | 4,182 | 78,245 | 620,938 | 625.1 K to 620.9 K (-0.67 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 16,021 | 0 | 625,120 | 609.1 K to 625.1 K (+2.63 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Payment of Exercise | F | 18.71 | 454 | 8,494 | 11,080 | 11.5 K to 11.1 K (-3.94 %) |
Feb 18 2021 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Grant | A | 0.00 | 1,325 | 0 | 11,534 | 10.2 K to 11.5 K (+12.98 %) |
Feb 09 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | M | 5.14 | 20,000 | 102,800 | 0 | |
Feb 09 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Payment of Exercise | F | 19.81 | 5,190 | 102,814 | 40,839 | 46 K to 40.8 K (-11.28 %) |
Feb 09 2021 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Buy | M | 5.14 | 20,000 | 102,800 | 46,029 | 26 K to 46 K (+76.84 %) |
Jan 12 2021 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Sell | S | 20.00 | 65,000 | 1,300,000 | 609,099 | 674.1 K to 609.1 K (-9.64 %) |
Dec 31 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 17.48 | 1,733 | 30,293 | 26,029 | 27.8 K to 26 K (-6.24 %) |
Dec 30 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Sell | S | 17.81 | 371 | 6,608 | 63,240 | 63.6 K to 63.2 K (-0.58 %) |
Dec 30 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 1,500 | 0 | 63,611 | 62.1 K to 63.6 K (+2.42 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 17.81 | 567 | 10,098 | 27,762 | 28.3 K to 27.8 K (-2.00 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 2,300 | 0 | 28,329 | 26 K to 28.3 K (+8.84 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Sell | S | 17.81 | 916 | 16,314 | 248,345 | 249.3 K to 248.3 K (-0.37 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Sell | S | 17.81 | 916 | 16,314 | 248,345 | 249.3 K to 248.3 K (-0.37 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 2,300 | 0 | 249,261 | 247 K to 249.3 K (+0.93 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 2,300 | 0 | 249,261 | 247 K to 249.3 K (+0.93 %) |
Dec 30 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Sell | S | 17.81 | 1,293 | 23,028 | 10,376 | 11.7 K to 10.4 K (-11.08 %) |
Dec 30 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 5,250 | 0 | 11,669 | 6.4 K to 11.7 K (+81.79 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Sell | S | 17.81 | 567 | 10,098 | 5,529 | 6.1 K to 5.5 K (-9.30 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Scopelianos Angelo | VP Research & Devel ... | Grant | A | 0.00 | 2,300 | 0 | 6,096 | 3.8 K to 6.1 K (+60.59 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Sell | S | 17.81 | 3,500 | 62,335 | 674,099 | 677.6 K to 674.1 K (-0.52 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 8,800 | 0 | 677,599 | 668.8 K to 677.6 K (+1.32 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Sell | S | 17.81 | 567 | 10,098 | 11,124 | 11.7 K to 11.1 K (-4.85 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 2,300 | 0 | 11,691 | 9.4 K to 11.7 K (+24.49 %) |
Dec 30 2020 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Sell | S | 17.81 | 567 | 10,098 | 4,665 | 5.2 K to 4.7 K (-10.84 %) |
Dec 30 2020 | LECT | Axogen, Inc. | MARTINEZ MARIA D. | Chief Human Resourc ... | Grant | A | 0.00 | 2,300 | 0 | 5,232 | 2.9 K to 5.2 K (+78.44 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Sell | S | 17.81 | 649 | 11,559 | 9,496 | 10.1 K to 9.5 K (-6.40 %) |
Dec 30 2020 | LECT | Axogen, Inc. | Billet Isabelle | Chief Strategy and ... | Grant | A | 0.00 | 2,300 | 0 | 10,145 | 7.8 K to 10.1 K (+29.32 %) |
Dec 28 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Option Exercise | M | 4.81 | 19,375 | 93,194 | 0 | |
Dec 28 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Buy | M | 4.81 | 19,375 | 93,194 | 666,094 | 646.7 K to 666.1 K (+3.00 %) |
Dec 23 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 17.19 | 279 | 4,796 | 26,029 | 26.3 K to 26 K (-1.06 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Sell | S | 16.42 | 1,275 | 20,936 | 646,719 | 648 K to 646.7 K (-0.20 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Zaderej Karen L. | CEO | Grant | A | 0.00 | 3,125 | 0 | 647,994 | 644.9 K to 648 K (+0.48 %) |
Dec 22 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Sell | S | 16.42 | 147 | 2,414 | 62,111 | 62.3 K to 62.1 K (-0.24 %) |
Dec 22 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Grant | A | 0.00 | 575 | 0 | 62,258 | 61.7 K to 62.3 K (+0.93 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Sell | S | 16.42 | 379 | 6,223 | 245,076 | 245.5 K to 245.1 K (-0.15 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Grant | A | 0.00 | 925 | 0 | 245,455 | 244.5 K to 245.5 K (+0.38 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 16.42 | 96 | 1,576 | 26,308 | 26.4 K to 26.3 K (-0.36 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Grant | A | 0.00 | 375 | 0 | 26,404 | 26 K to 26.4 K (+1.44 %) |
Dec 22 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Sell | S | 16.42 | 481 | 7,898 | 6,419 | 6.9 K to 6.4 K (-6.97 %) |
Dec 22 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Grant | A | 0.00 | 1,900 | 0 | 6,900 | 5 K to 6.9 K (+38.00 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Sell | S | 16.42 | 96 | 1,576 | 8,893 | 9 K to 8.9 K (-1.07 %) |
Dec 22 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Grant | A | 0.00 | 375 | 0 | 8,989 | 8.6 K to 9 K (+4.35 %) |
Dec 17 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Option Exercise | M | 4.81 | 15,000 | 72,150 | 0 | |
Dec 17 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Payment of Exercise | F | 16.50 | 4,373 | 72,155 | 61,683 | 66.1 K to 61.7 K (-6.62 %) |
Dec 17 2020 | LECT | Axogen, Inc. | DeVinney Erick Wayne | VP, Clinical&Transl ... | Buy | M | 4.81 | 15,000 | 72,150 | 66,056 | 51.1 K to 66.1 K (+29.38 %) |
Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 3.67 | 3,187 | 11,696 | 0 | |
Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Option Exercise | M | 4.81 | 625 | 3,006 | 0 | |
Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 3.67 | 3,187 | 11,696 | 8,614 | 5.4 K to 8.6 K (+58.72 %) |
Dec 07 2020 | LECT | Axogen, Inc. | Friedman Mark Louis | VP,Regulatory & Qua ... | Buy | M | 4.81 | 625 | 3,006 | 5,427 | 4.8 K to 5.4 K (+13.02 %) |
Nov 12 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Sell | S | 15.00 | 17,617 | 264,255 | 26,029 | 43.6 K to 26 K (-40.36 %) |
Nov 05 2020 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Gift | G | 0.00 | 15,596 | 0 | 296,266 | 311.9 K to 296.3 K (-5.00 %) |
Nov 03 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Option Exercise | M | 5.04 | 60,000 | 302,400 | 145,000 | |
Nov 03 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Sell | S | 12.41 | 1,745 | 21,662 | 5,000 | 6.7 K to 5 K (-25.87 %) |
Nov 03 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Sell | S | 12.41 | 12,854 | 159,518 | 6,745 | 19.6 K to 6.7 K (-65.58 %) |
Nov 03 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Sell | S | 12.41 | 1,084 | 13,452 | 19,599 | 20.7 K to 19.6 K (-5.24 %) |
Nov 03 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Sell | S | 12.41 | 60,000 | 744,720 | 20,683 | 80.7 K to 20.7 K (-74.37 %) |
Nov 03 2020 | LECT | Axogen, Inc. | MARIANI PETER J | Chief Financial Off ... | Buy | M | 5.04 | 60,000 | 302,400 | 80,683 | 20.7 K to 80.7 K (+290.09 %) |
Sep 17 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Option Exercise | M | 3.67 | 4,046 | 14,849 | 22,954 | |
Sep 17 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Option Exercise | M | 3.67 | 9,000 | 33,030 | 24,000 | |
Sep 17 2020 | LECT | Axogen, Inc. | Freitag Gregory Gene | Director | Buy | M | 3.67 | 13,046 | 47,879 | 244,530 | 231.5 K to 244.5 K (+5.64 %) |
Sep 08 2020 | LECT | Axogen, Inc. | NEELS GUIDO J | Director | Grant | A | 11.75 | 2,591 | 30,444 | 2,591 | 0 to 2.6 K |
Sep 08 2020 | LECT | Axogen, Inc. | Rudelius Robert James | Director | Grant | A | 11.75 | 2,591 | 30,444 | 48,183 | 45.6 K to 48.2 K (+5.68 %) |
Sep 08 2020 | LECT | Axogen, Inc. | Wendell Amy McBride | Director | Grant | A | 11.75 | 2,591 | 30,444 | 25,924 | 23.3 K to 25.9 K (+11.10 %) |
Sep 08 2020 | LECT | Axogen, Inc. | Levine Alan M | Director | Grant | A | 11.75 | 2,591 | 30,444 | 2,591 | 0 to 2.6 K |
Sep 08 2020 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Grant | A | 11.75 | 2,591 | 30,444 | 18,126 | 15.5 K to 18.1 K (+16.68 %) |
Sep 08 2020 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Grant | A | 11.75 | 2,591 | 30,444 | 311,862 | 309.3 K to 311.9 K (+0.84 %) |
Aug 13 2020 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Gift | G | 0.00 | 17,500 | 0 | 309,271 | 326.8 K to 309.3 K (-5.36 %) |
Jun 03 2020 | LECT | Axogen, Inc. | NEELS GUIDO J | Director | Option Exercise | A | 0.00 | 4,115 | 0 | 4,115 | |
Jun 03 2020 | LECT | Axogen, Inc. | NEELS GUIDO J | Director | Option Exercise | A | 9.72 | 16,807 | 163,364 | 16,807 | |
Jun 03 2020 | LECT | Axogen, Inc. | Levine Alan M | Director | Option Exercise | A | 0.00 | 2,591 | 0 | 2,591 | |
Jun 03 2020 | LECT | Axogen, Inc. | Levine Alan M | Director | Option Exercise | A | 15.44 | 10,710 | 165,362 | 10,710 | |
Jun 03 2020 | LECT | Axogen, Inc. | Wendell Amy McBride | Director | Option Exercise | A | 0.00 | 4,115 | 0 | 4,115 | |
Jun 03 2020 | LECT | Axogen, Inc. | Wendell Amy McBride | Director | Option Exercise | A | 9.72 | 16,807 | 163,364 | 16,807 | |
Jun 03 2020 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Option Exercise | A | 0.00 | 4,115 | 0 | 4,115 | |
Jun 03 2020 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Option Exercise | A | 9.72 | 16,807 | 163,364 | 16,807 | |
Jun 03 2020 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Option Exercise | A | 0.00 | 4,115 | 0 | 4,115 | |
Jun 03 2020 | LECT | Axogen, Inc. | Blackford Quentin S. | Director | Option Exercise | A | 9.72 | 16,807 | 163,364 | 16,807 | |
Jun 03 2020 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Option Exercise | A | 0.00 | 2,591 | 0 | 2,591 | |
Jun 03 2020 | LECT | Axogen, Inc. | Gold Mark Stephen | Director | Option Exercise | A | 15.44 | 10,710 | 165,362 | 10,710 | |
Jun 01 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | M | 5.14 | 5,000 | 25,700 | 20,000 | |
Jun 01 2020 | LECT | Axogen, Inc. | Donovan Michael Patrick | VP Operations | Option Exercise | M | 3.67 | 10,000 | 36,700 | 0 |